Free Trial
Guggenheim

Guggenheim Analyst Recommendations & Stock Picks

View the latest stock recommendations issued by analysts at Guggenheim. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Guggenheim's equity research team. MarketBeat is not affiliated with or endorsed by Guggenheim.

Average Return
00.00% 12-Month ROI
Total Ratings
985 Last 12 Months
Buy Ratings
824 Last 12 Months
Sell Ratings
13 Last 12 Months
Companies Covered
370 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
Illumina, Inc. stock logo
ILMN
Illumina
$162.09
-0.5%
6/1/2026Boost Price Target$170.00 ➝ $180.00BuyView details for Guggenheim rating of Illumina (NASDAQ:ILMN) on 6/1/2026
Oculis Holding AG stock logo
OCS
Oculis
$15.70
-30.8%
6/1/2026Lower Price Target$75.00 ➝ $45.00BuyView details for Guggenheim rating of Oculis (NASDAQ:OCS) on 6/1/2026
Dollar Tree, Inc. stock logo
DLTR
Dollar Tree
$115.90
-0.5%
5/29/2026Boost Price Target$130.00 ➝ $135.00BuyView details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 5/29/2026
Best Buy Co., Inc. stock logo
BBY
Best Buy
$75.78
-2.8%
5/29/2026Reiterated Rating$90.00BuyView details for Guggenheim rating of Best Buy (NYSE:BBY) on 5/29/2026
MongoDB, Inc. stock logo
MDB
MongoDB
$353.46
+5.3%
5/29/2026Reiterated Rating$475.00BuyView details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 5/29/2026
Guardant Health, Inc. stock logo
GH
Guardant Health
$127.36
-1.8%
5/28/2026 DowngradeBuyView details for Guggenheim rating of Guardant Health (NASDAQ:GH) on 5/28/2026
Everpure, Inc. stock logo
P
Everpure
$81.53
+2.5%
5/28/2026Boost Price Target$105.00 ➝ $115.00BuyView details for Guggenheim rating of Everpure (NYSE:P) on 5/28/2026
Assembly Biosciences, Inc. stock logo
ASMB
Assembly Biosciences
$28.42
+2.7%
5/28/2026Reiterated Rating$43.00BuyView details for Guggenheim rating of Assembly Biosciences (NASDAQ:ASMB) on 5/28/2026
Dycom Industries, Inc. stock logo
DY
Dycom Industries
$504.59
-1.1%
5/28/2026Boost Price Target$575.00 ➝ $620.00BuyView details for Guggenheim rating of Dycom Industries (NYSE:DY) on 5/28/2026
Jack In The Box Inc. stock logo
JACK
Jack In The Box
$12.66
+1.7%
5/28/2026DowngradeBuyNeutralView details for Guggenheim rating of Jack In The Box (NASDAQ:JACK) on 5/28/2026
AutoZone, Inc. stock logo
AZO
AutoZone
$2,949.65
+0.5%
5/27/2026Lower Price Target$4,400.00 ➝ $4,000.00BuyView details for Guggenheim rating of AutoZone (NYSE:AZO) on 5/27/2026
Par Pacific Holdings, Inc. stock logo
PARR
Par Pacific
$56.95
+1.4%
5/27/2026 UpgradeOutperformView details for Guggenheim rating of Par Pacific (NYSE:PARR) on 5/27/2026
Phillips 66 stock logo
PSX
Phillips 66
$177.87
+1.1%
5/27/2026 UpgradeOutperformView details for Guggenheim rating of Phillips 66 (NYSE:PSX) on 5/27/2026
CrowdStrike stock logo
CRWD
CrowdStrike
$754.69
+3.2%
5/27/2026 Reiterated RatingNeutralView details for Guggenheim rating of CrowdStrike (NASDAQ:CRWD) on 5/27/2026
Palo Alto Networks, Inc. stock logo
PANW
Palo Alto Networks
$287.44
+2.0%
5/27/2026 DowngradeNeutralReduceView details for Guggenheim rating of Palo Alto Networks (NASDAQ:PANW) on 5/27/2026
Endava PLC Sponsored ADR stock logo
DAVA
Endava
$3.25
+1.1%
5/27/2026DowngradeBuyNeutralView details for Guggenheim rating of Endava (NYSE:DAVA) on 5/27/2026
Zscaler, Inc. stock logo
ZS
Zscaler
$149.35
+6.9%
5/27/2026Reiterated RatingNeutralView details for Guggenheim rating of Zscaler (NASDAQ:ZS) on 5/27/2026
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
$7.88
-0.4%
5/26/2026Reiterated RatingBuyView details for Guggenheim rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 5/26/2026
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
$29.38
-2.0%
5/26/2026Boost Price Target$30.00 ➝ $36.00BuyView details for Guggenheim rating of Roivant Sciences (NASDAQ:ROIV) on 5/26/2026
Restaurant Brands International Inc. stock logo
QSR
Restaurant Brands International
$74.55
-0.2%
5/26/2026Boost Price Target$80.00 ➝ $85.00BuyView details for Guggenheim rating of Restaurant Brands International (NYSE:QSR) on 5/26/2026
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
$13.78
-2.0%
5/26/2026Boost Price Target$22.00 ➝ $26.00BuyView details for Guggenheim rating of Relay Therapeutics (NASDAQ:RLAY) on 5/26/2026
Immunovant, Inc. stock logo
IMVT
Immunovant
$32.67
-1.9%
5/26/2026Boost Price Target$44.00 ➝ $62.00BuyView details for Guggenheim rating of Immunovant (NASDAQ:IMVT) on 5/26/2026
SOLV Energy Inc. stock logo
MWH
SOLV Energy
$34.88
-1.8%
5/26/2026Boost Price Target$37.00 ➝ $50.00BuyView details for Guggenheim rating of SOLV Energy (NASDAQ:MWH) on 5/26/2026
Avalyn Pharma Inc. stock logo
AVLN
Avalyn Pharma
$28.78
5/25/2026Initiated Coverage$80.00BuyView details for Guggenheim rating of Avalyn Pharma (NASDAQ:AVLN) on 5/25/2026
Avalyn Pharma Inc. stock logo
AVLN
Avalyn Pharma
$28.78
5/25/2026UpgradeStrong-BuyView details for Guggenheim rating of Avalyn Pharma (NASDAQ:AVLN) on 5/25/2026
Shoals Technologies Group, Inc. stock logo
SHLS
Shoals Technologies Group
$12.20
-2.0%
5/22/2026 Reiterated RatingBuyView details for Guggenheim rating of Shoals Technologies Group (NASDAQ:SHLS) on 5/22/2026
Ameresco, Inc. stock logo
AMRC
Ameresco
$35.27
-2.0%
5/22/2026 Initiated CoverageNeutralView details for Guggenheim rating of Ameresco (NYSE:AMRC) on 5/22/2026
Etsy Inc stock logo
ETSY
Etsy
$69.26
+2.0%
5/21/2026Initiated CoverageBuyView details for Guggenheim rating of Etsy (NYSE:ETSY) on 5/21/2026
First Solar, Inc. stock logo
FSLR
First Solar
$298.77
-2.6%
5/21/2026Boost Price Target$269.00 ➝ $279.00BuyView details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 5/21/2026
Oculis Holding AG stock logo
OCS
Oculis
$15.70
-30.8%
5/20/2026Initiated Coverage$75.00BuyView details for Guggenheim rating of Oculis (NASDAQ:OCS) on 5/20/2026
The Home Depot, Inc. stock logo
HD
Home Depot
$311.01
-1.9%
5/20/2026Reiterated Rating$425.00BuyView details for Guggenheim rating of Home Depot (NYSE:HD) on 5/20/2026
Target Corporation stock logo
TGT
Target
$125.62
-1.1%
5/20/2026Reiterated Rating$140.00BuyView details for Guggenheim rating of Target (NYSE:TGT) on 5/20/2026
Wayfair Inc. stock logo
W
Wayfair
$72.45
+0.3%
5/20/2026Reiterated Rating$100.00BuyView details for Guggenheim rating of Wayfair (NYSE:W) on 5/20/2026
Equinix, Inc. stock logo
EQIX
Equinix
$1,053.49
-1.4%
5/20/2026Reiterated Rating$1,235.00BuyView details for Guggenheim rating of Equinix (NASDAQ:EQIX) on 5/20/2026
Oculis Holding AG stock logo
OCS
Oculis
$15.70
-30.8%
5/20/2026UpgradeStrong-BuyView details for Guggenheim rating of Oculis (NASDAQ:OCS) on 5/20/2026
STUB stock logo
STUB
STUB
$9.89
+0.3%
5/19/2026Upgrade$8.50 ➝ $12.50NeutralBuyView details for Guggenheim rating of STUB (NYSE:STUB) on 5/19/2026
X-Energy, Inc. stock logo
XE
X-Energy
$26.60
-1.2%
5/19/2026Initiated Coverage$57.00BuyView details for Guggenheim rating of X-Energy (NASDAQ:XE) on 5/19/2026
Elastic N.V. stock logo
ESTC
Elastic
$63.97
-1.1%
5/19/2026Lower Price Target$116.00 ➝ $106.00BuyView details for Guggenheim rating of Elastic (NYSE:ESTC) on 5/19/2026
X-Energy, Inc. stock logo
XE
X-Energy
$26.60
-1.2%
5/19/2026Initiated Coverage$57.00BuyView details for Guggenheim rating of X-Energy (NASDAQ:XE) on 5/19/2026
Texas Roadhouse, Inc. stock logo
TXRH
Texas Roadhouse
$180.73
+0.1%
5/18/2026Reiterated Rating$210.00BuyView details for Guggenheim rating of Texas Roadhouse (NASDAQ:TXRH) on 5/18/2026
$30 stock to buy before Starlink goes public (WATCH NOW!) (Ad)

A little-known stock pick with money-doubling potential over the next year is revealed for free in the first three minutes of a new video. This company is a critical piece of Elon Musk's fast-growing Starlink technology. It could climb 100 percent or more over the next year as Elon brings Starlink public in what may be the biggest IPO in history. No credit card is required to get the ticker.tc pixel

Watch the free video to get the ticker today.
Yesway, Inc. stock logo
YSWY
Yesway
$22.50
5/18/2026Initiated Coverage$30.00BuyView details for Guggenheim rating of Yesway (NASDAQ:YSWY) on 5/18/2026
STUB stock logo
STUB
STUB
$9.89
+0.3%
5/15/2026Boost Price Target$7.50 ➝ $8.50NeutralView details for Guggenheim rating of STUB (NYSE:STUB) on 5/15/2026
Gray Media Inc. stock logo
GTN
Gray Media
$4.01
0.0%
5/15/2026Lower Price Target$8.00 ➝ $7.00BuyView details for Guggenheim rating of Gray Media (NYSE:GTN) on 5/15/2026
Alumis Inc. stock logo
ALMS
Alumis
$21.12
-2.2%
5/15/2026Boost Price Target$32.00 ➝ $34.00BuyView details for Guggenheim rating of Alumis (NASDAQ:ALMS) on 5/15/2026
The Madison Square Garden Company stock logo
MSGS
Madison Square Garden
$376.24
+0.5%
5/15/2026Boost Price Target$401.00 ➝ $422.00BuyView details for Guggenheim rating of Madison Square Garden (NYSE:MSGS) on 5/15/2026
Netflix, Inc. stock logo
NFLX
Netflix
$86.53
+0.6%
5/15/2026Reiterated Rating$120.00BuyView details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 5/15/2026
Unicycive Therapeutics, Inc. stock logo
UNCY
Unicycive Therapeutics
$7.61
+3.1%
5/13/2026Reiterated Rating$40.00 ➝ $37.00BuyView details for Guggenheim rating of Unicycive Therapeutics (NASDAQ:UNCY) on 5/13/2026
Billiontoone, Inc. stock logo
BLLN
Billiontoone
$96.84
-2.2%
5/13/2026Boost Price Target$100.00 ➝ $120.00BuyView details for Guggenheim rating of Billiontoone (NASDAQ:BLLN) on 5/13/2026
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
$7.88
-0.4%
5/13/2026Reiterated Rating$45.00BuyView details for Guggenheim rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 5/13/2026
Dynatrace, Inc. stock logo
DT
Dynatrace
$43.31
+1.7%
5/13/2026DowngradeBuyNeutralView details for Guggenheim rating of Dynatrace (NYSE:DT) on 5/13/2026
MasTec, Inc. stock logo
MTZ
MasTec
$372.99
-1.4%
5/13/2026Upgrade$480.00NeutralBuyView details for Guggenheim rating of MasTec (NYSE:MTZ) on 5/13/2026
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
$12.97
-1.7%
5/13/2026Lower Price Target$38.00 ➝ $35.00BuyView details for Guggenheim rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 5/13/2026
On Holding AG stock logo
ONON
ON
$41.28
+1.1%
5/13/2026Reiterated Rating$51.00BuyView details for Guggenheim rating of ON (NYSE:ONON) on 5/13/2026
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
$39.08
-1.3%
5/12/2026 Initiated Coverage$80.00BuyView details for Guggenheim rating of Enliven Therapeutics (NASDAQ:ELVN) on 5/12/2026
DraftKings Inc. stock logo
DKNG
DraftKings
$25.74
+5.1%
5/11/2026Lower Price Target$37.00 ➝ $35.00BuyView details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 5/11/2026
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
$18.84
-10.5%
5/11/2026Boost Price Target$23.00 ➝ $32.00BuyView details for Guggenheim rating of Jade Biosciences (NASDAQ:JBIO) on 5/11/2026
Coherus Oncology, Inc. stock logo
CHRS
Coherus Oncology
$1.62
+1.6%
5/11/2026 Initiated Coverage$12.00BuyView details for Guggenheim rating of Coherus Oncology (NASDAQ:CHRS) on 5/11/2026
Bicara Therapeutics Inc. stock logo
BCAX
Bicara Therapeutics
$20.79
-4.4%
5/11/2026Initiated Coverage$42.00BuyView details for Guggenheim rating of Bicara Therapeutics (NASDAQ:BCAX) on 5/11/2026
Coherus Oncology, Inc. stock logo
CHRS
Coherus Oncology
$1.62
+1.6%
5/11/2026 Initiated Coverage$12.00BuyView details for Guggenheim rating of Coherus Oncology (NASDAQ:CHRS) on 5/11/2026
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
$39.08
-1.3%
5/11/2026 UpgradeStrong-BuyView details for Guggenheim rating of Enliven Therapeutics (NASDAQ:ELVN) on 5/11/2026
Shake Shack, Inc. stock logo
SHAK
Shake Shack
$64.09
-0.3%
5/11/2026Lower Price Target$120.00 ➝ $100.00BuyView details for Guggenheim rating of Shake Shack (NYSE:SHAK) on 5/11/2026
Bicara Therapeutics Inc. stock logo
BCAX
Bicara Therapeutics
$20.79
-4.4%
5/10/2026UpgradeStrong-BuyView details for Guggenheim rating of Bicara Therapeutics (NASDAQ:BCAX) on 5/10/2026
Zevra Therapeutics, Inc. stock logo
ZVRA
Zevra Therapeutics
$11.49
-0.9%
5/8/2026Boost Price Target$23.00 ➝ $25.00BuyView details for Guggenheim rating of Zevra Therapeutics (NASDAQ:ZVRA) on 5/8/2026
Insmed, Inc. stock logo
INSM
Insmed
$105.16
-1.6%
5/8/2026Lower Price Target$230.00 ➝ $226.00BuyView details for Guggenheim rating of Insmed (NASDAQ:INSM) on 5/8/2026
Warner Music Group Corp. stock logo
WMG
Warner Music Group
$31.71
+0.5%
5/8/2026Boost Price Target$34.00 ➝ $36.00BuyView details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 5/8/2026
JFrog Ltd. stock logo
FROG
JFrog
$81.70
+2.8%
5/8/2026Boost Price Target$60.00 ➝ $80.00BuyView details for Guggenheim rating of JFrog (NASDAQ:FROG) on 5/8/2026
Akamai Technologies, Inc. stock logo
AKAM
Akamai Technologies
$150.59
+0.7%
5/8/2026Boost Price Target$133.00 ➝ $181.00BuyView details for Guggenheim rating of Akamai Technologies (NASDAQ:AKAM) on 5/8/2026
argenex SE stock logo
ARGX
argenex
$829.61
-0.8%
5/8/2026Boost Price Target$1,120.00 ➝ $1,135.00BuyView details for Guggenheim rating of argenex (NASDAQ:ARGX) on 5/8/2026
Arhaus, Inc. stock logo
ARHS
Arhaus
$6.70
-1.0%
5/8/2026Lower Price Target$14.00 ➝ $12.00BuyView details for Guggenheim rating of Arhaus (NASDAQ:ARHS) on 5/8/2026
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
$14.32
-1.9%
5/8/2026Lower Price Target$68.00 ➝ $58.00BuyView details for Guggenheim rating of Janux Therapeutics (NASDAQ:JANX) on 5/8/2026
Planet Fitness, Inc. stock logo
PLNT
Planet Fitness
$52.76
-1.4%
5/8/2026Lower Price Target$126.00 ➝ $95.00BuyView details for Guggenheim rating of Planet Fitness (NYSE:PLNT) on 5/8/2026
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
$23.43
-2.2%
5/8/2026Lower Price Target$52.00 ➝ $43.00BuyView details for Guggenheim rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 5/8/2026
The Trade Desk stock logo
TTD
Trade Desk
$22.66
+5.1%
5/8/2026Lower Price Target$28.00 ➝ $25.00BuyView details for Guggenheim rating of Trade Desk (NASDAQ:TTD) on 5/8/2026
enGene Holdings Inc. stock logo
ENGN
enGene
$1.83
-1.1%
5/7/2026DowngradeBuyNeutralView details for Guggenheim rating of enGene (NASDAQ:ENGN) on 5/7/2026
Datadog, Inc. stock logo
DDOG
Datadog
$256.77
+3.8%
5/7/2026Boost Price Target$175.00 ➝ $225.00BuyView details for Guggenheim rating of Datadog (NASDAQ:DDOG) on 5/7/2026
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
$283.46
-1.5%
5/7/2026Boost Price Target$410.00 ➝ $420.00BuyView details for Guggenheim rating of BeOne Medicines (NASDAQ:ONC) on 5/7/2026
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
$155.24
-1.4%
5/7/2026Boost Price Target$205.00BuyView details for Guggenheim rating of Revolution Medicines (NASDAQ:RVMD) on 5/7/2026
Portillo's Inc. stock logo
PTLO
Portillo's
$4.34
+1.0%
5/7/2026DowngradeBuyNeutralView details for Guggenheim rating of Portillo’s (NASDAQ:PTLO) on 5/7/2026
ARM Holdings PLC Sponsored ADR stock logo
ARM
ARM
$409.67
+16.0%
5/7/2026Boost Price Target$240.00 ➝ $255.00BuyView details for Guggenheim rating of ARM (NASDAQ:ARM) on 5/7/2026
The Walt Disney Company stock logo
DIS
Walt Disney
$100.88
-0.9%
5/7/2026Boost Price Target$115.00 ➝ $120.00BuyView details for Guggenheim rating of Walt Disney (NYSE:DIS) on 5/7/2026
The New York Times Company stock logo
NYT
New York Times
$74.72
-0.7%
5/7/2026Boost Price Target$63.00 ➝ $70.00NeutralView details for Guggenheim rating of New York Times (NYSE:NYT) on 5/7/2026
Warner Bros. Discovery, Inc. stock logo
WBD
Warner Bros. Discovery
$27.05
+0.1%
5/7/2026Reiterated RatingNeutralView details for Guggenheim rating of Warner Bros. Discovery (NASDAQ:WBD) on 5/7/2026
Sphere Entertainment Co. stock logo
SPHR
Sphere Entertainment
$139.68
+0.9%
5/6/2026Boost Price Target$160.00 ➝ $175.00BuyView details for Guggenheim rating of Sphere Entertainment (NYSE:SPHR) on 5/6/2026
Live Nation Entertainment, Inc. stock logo
LYV
Live Nation Entertainment
$168.53
+0.1%
5/6/2026Boost Price Target$192.00 ➝ $197.00BuyView details for Guggenheim rating of Live Nation Entertainment (NYSE:LYV) on 5/6/2026
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
$14.82
-2.2%
5/6/2026Reiterated Rating$21.00BuyView details for Guggenheim rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 5/6/2026
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$158.42
+0.1%
5/6/2026Reiterated Rating$175.00BuyView details for Guggenheim rating of Neurocrine Biosciences (NASDAQ:NBIX) on 5/6/2026
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
$65.96
-1.4%
5/5/2026Boost Price Target$55.00 ➝ $60.00BuyView details for Guggenheim rating of Twist Bioscience (NASDAQ:TWST) on 5/5/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
$15.71
+0.1%
5/5/2026Boost Price Target$11.00 ➝ $12.00BuyView details for Guggenheim rating of CryoPort (NASDAQ:CYRX) on 5/5/2026
Aclaris Therapeutics, Inc. stock logo
ACRS
Aclaris Therapeutics
$4.51
-0.9%
5/5/2026Initiated Coverage$12.00BuyView details for Guggenheim rating of Aclaris Therapeutics (NASDAQ:ACRS) on 5/5/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,088.37
-1.5%
5/5/2026Reiterated Rating$1,183.00BuyView details for Guggenheim rating of Eli Lilly and Company (NYSE:LLY) on 5/5/2026
Your book attached (Ad)

Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel

Download the Safe Trade Options Formula book for free before access closes
Pinterest, Inc. stock logo
PINS
Pinterest
$20.48
+2.2%
5/5/2026Boost Price Target$21.00 ➝ $24.00BuyView details for Guggenheim rating of Pinterest (NYSE:PINS) on 5/5/2026
Paramount Skydance Corporation stock logo
PSKY
Paramount Skydance
$10.61
0.0%
5/5/2026Lower Price Target$14.00 ➝ $12.00NeutralView details for Guggenheim rating of Paramount Skydance (NASDAQ:PSKY) on 5/5/2026
Sinclair, Inc. stock logo
SBGI
Sinclair
$14.06
+1.6%
5/5/2026Lower Price Target$20.00 ➝ $19.00BuyView details for Guggenheim rating of Sinclair (NASDAQ:SBGI) on 5/5/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$50.89
-2.1%
5/5/2026Lower Price Target$100.00 ➝ $70.00BuyView details for Guggenheim rating of GeneDx (NASDAQ:WGS) on 5/5/2026
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
$231.54
-1.3%
5/4/2026Boost Price Target$245.00 ➝ $260.00BuyView details for Guggenheim rating of Axsome Therapeutics (NASDAQ:AXSM) on 5/4/2026
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
$23.36
+0.7%
5/4/2026Boost Price Target$26.00 ➝ $31.00BuyView details for Guggenheim rating of Acadia Healthcare (NASDAQ:ACHC) on 5/4/2026
Celcuity, Inc. stock logo
CELC
Celcuity
$129.35
-2.7%
5/4/2026Boost Price Target$135.00 ➝ $165.00BuyView details for Guggenheim rating of Celcuity (NASDAQ:CELC) on 5/4/2026
Aclaris Therapeutics, Inc. stock logo
ACRS
Aclaris Therapeutics
$4.51
-0.9%
5/4/2026UpgradeStrong-BuyView details for Guggenheim rating of Aclaris Therapeutics (NASDAQ:ACRS) on 5/4/2026
Amgen Inc. stock logo
AMGN
Amgen
$330.15
-2.0%
5/4/2026Lower Price Target$351.00 ➝ $340.00NeutralView details for Guggenheim rating of Amgen (NASDAQ:AMGN) on 5/4/2026
Cigna Group stock logo
CI
Cigna Group
$275.64
-0.6%
5/4/2026Boost Price Target$334.00 ➝ $338.00BuyView details for Guggenheim rating of Cigna Group (NYSE:CI) on 5/4/2026

MarketBeat's community ratings are surveys of what our community members think about Guggenheim and other research firms in the last 90 days. Vote "Outperform" if you believe Guggenheim's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe Guggenheim's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.
COMMUNITY RATINGS
2.6out of 5 (last 90 days)
2.6 of 5 stars
OUTPERFORM VOTES
25 Believe will outperform the market
UNDERPERFORM VOTES
24 Believe will underperform the market

Guggenheim's equity research team has issued ratings on 366 companies across 16 sectors over the past 12 months, covered by 33 analysts. The Guggenheim analysts below are listed by number of ratings issued in the last year.

Guggenheim Stock Coverage by Sector

Guggenheim concentrates its research most heavily in Medical (46.5%), Computer and Technology (14.9%) and Retail/Wholesale (14.1%). The chart below shows how Guggenheim's 370 rated companies are distributed across all 16 sectors it covers.

Guggenheim - Frequently Asked Questions

Guggenheim's analysts currently have buy-equivalent ratings on 315 companies. Recent upgrades to buy include Zscaler, Par Pacific, Phillips 66, Avalyn Pharma and Oculis.

Guggenheim's highest-rated analysts by MarketBeat's accuracy score include Seamus Fernandez, Joseph Osha and Vamil Divan. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 33 analysts at Guggenheim.

Guggenheim has the deepest coverage in Medical (46.5% of rated companies), Computer and Technology (14.9% of rated companies), Retail/Wholesale (14.1% of rated companies), Consumer Discretionary (11.1% of rated companies) and Energy (3.0% of rated companies).

Guggenheim issued 985 ratings over the last 12 months across 370 companies — an average of roughly 82 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current Guggenheim analyst actions.

A buy rating indicates the analyst expects the stock to outperform the market over the next 12 months. A hold suggests the stock will perform in line with the market. A sell rating indicates expected underperformance. Guggenheim uses Buy, Neutral, and Sell as their equivalents.